Tags

Type your tag names separated by a space and hit enter

[Drug therapy of arterial diseases. A study with Trental 400].
Fortschr Med. 1980 Dec 04; 98(45):1795-8.FM

Abstract

28 patients suffering from peripheral vascular disorders in the lower extremities (Fontaine classification: Stage II = 25, Stage I-II = 3 patients) were treated for a period of 4 weeks with daily 2 to 3 tablets Trental 400 (= 400 mg pentoxifylline per talbet). Judging by extension of walking distance, increase in performance in ergometric and standing on toe testing as well as on alleviation of subjective symptoms 17 patients improved distinctly and 8 moderately, 3 patients remained unaltered. The drug was well tolerated subjectively and objectively.

Authors

Tannenberg G
No affiliation info available

MeSH

AdultArterial Occlusive DiseasesBlood PressureDrug EvaluationDrug ToleranceHumansMaleMiddle AgedPentoxifyllinePhysical ExertionTheobromine

Pub Type(s)

English Abstract
Journal Article

Language

ger

PubMed ID

7461576

Citation

Tannenberg, G. "[Drug Therapy of Arterial Diseases. a Study With Trental 400]." Fortschritte Der Medizin, vol. 98, no. 45, 1980, pp. 1795-8.
Tannenberg G. [Drug therapy of arterial diseases. A study with Trental 400]. Fortschr Med. 1980;98(45):1795-8.
Tannenberg, G. (1980). [Drug therapy of arterial diseases. A study with Trental 400]. Fortschritte Der Medizin, 98(45), 1795-8.
Tannenberg G. [Drug Therapy of Arterial Diseases. a Study With Trental 400]. Fortschr Med. 1980 Dec 4;98(45):1795-8. PubMed PMID: 7461576.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Drug therapy of arterial diseases. A study with Trental 400]. A1 - Tannenberg,G, PY - 1980/12/4/pubmed PY - 1980/12/4/medline PY - 1980/12/4/entrez SP - 1795 EP - 8 JF - Fortschritte der Medizin JO - Fortschr Med VL - 98 IS - 45 N2 - 28 patients suffering from peripheral vascular disorders in the lower extremities (Fontaine classification: Stage II = 25, Stage I-II = 3 patients) were treated for a period of 4 weeks with daily 2 to 3 tablets Trental 400 (= 400 mg pentoxifylline per talbet). Judging by extension of walking distance, increase in performance in ergometric and standing on toe testing as well as on alleviation of subjective symptoms 17 patients improved distinctly and 8 moderately, 3 patients remained unaltered. The drug was well tolerated subjectively and objectively. SN - 0015-8178 UR - https://www.unboundmedicine.com/medline/citation/7461576/[Drug_therapy_of_arterial_diseases__A_study_with_Trental_400]_ DB - PRIME DP - Unbound Medicine ER -